Europe Antibiotics Market Size, Share & Trends Report

Europe Antibiotics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Penicillin), By Type (Branded Antibodies, Generic Antibodies), By Action Mechanism, By Country, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-4-68040-240-7
  • Number of Pages: 80
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Market Segmentation

  • Europe Antibiotics Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
    • Cephalosporin
    • Penicillin
    • Fluoroquinolone
    • Macrolides
    • Carbapenems
    • Aminoglycosides
    • Sulfonamides
    • 7-ACA
    • Others
  • Europe Antibiotics Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Branded Antibiotics
    • Generic Antibiotics
  • Europe Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2018 - 2030)
    • Cell Wall Synthesis Inhibitors
    • Protein Synthesis Inhibitors
    • DNA Synthesis Inhibitors
    • RNA Synthesis Inhibitors
    • Mycolic Acid Inhibitors
    • Others
  • Europe Antibiotics Country Outlook (Revenue, USD Million, 2018 - 2030)
    • Europe
      • Europe Antibiotics Market, By Drug Class
        • Cephalosporin
        • Penicillin
        • Fluoroquinolone
        • Macrolides
        • Carbapenems
        • Aminoglycosides
        • Sulfonamides
        • 7-ACA
        • Others
      • Europe Antibiotics Market, By Type
        • Branded Antibiotics
        • Generic Antibiotics
      • Europe Antibiotics Market, By Action Mechanism
        • Cell Wall Synthesis Inhibitors
        • Protein Synthesis Inhibitors
        • DNA Synthesis Inhibitors
        • RNA Synthesis Inhibitors
        • Mycolic Acid Inhibitors
        • Others
      • Germany
        • Germany Antibiotics Market, By Drug Class
          • Cephalosporin
          • Penicillin
          • Fluoroquinolone
          • Macrolides
          • Carbapenems
          • Aminoglycosides
          • Sulfonamides
          • 7-ACA
          • Others
        • Germany Antibiotics Market, By Type
          • Branded Antibiotics
          • Generic Antibiotics
        • Germany Antibiotics Market, By Action Mechanism
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • Mycolic Acid Inhibitors
          • Others
      • UK
        • UK Antibiotics Market, By Drug Class
          • Cephalosporin
          • Penicillin
          • Fluoroquinolone
          • Macrolides
          • Carbapenems
          • Aminoglycosides
          • Sulfonamides
          • 7-ACA
          • Others
        • UK Antibiotics Market, By Type
          • Branded Antibiotics
          • Generic Antibiotics
        • UK Antibiotics Market, By Action Mechanism
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • Mycolic Acid Inhibitors
          • Others
      • France
        • France Antibiotics Market, By Drug Class
          • Cephalosporin
          • Penicillin
          • Fluoroquinolone
          • Macrolides
          • Carbapenems
          • Aminoglycosides
          • Sulfonamides
          • 7-ACA
          • Others
        • France Antibiotics Market, By Type
          • Branded Antibiotics
          • Generic Antibiotics
        • France Antibiotics Market, By Action Mechanism
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • Mycolic Acid Inhibitors
          • Others
      • Italy
        • Italy Antibiotics Market, By Drug Class
          • Cephalosporin
          • Penicillin
          • Fluoroquinolone
          • Macrolides
          • Carbapenems
          • Aminoglycosides
          • Sulfonamides
          • 7-ACA
          • Others
        • Italy Antibiotics Market, By Type
          • Branded Antibiotics
          • Generic Antibiotics
        • Italy Antibiotics Market, By Action Mechanism
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • Mycolic Acid Inhibitors
          • Others
      • Spain
        • Spain Antibiotics Market, By Drug Class
          • Cephalosporin
          • Penicillin
          • Fluoroquinolone
          • Macrolides
          • Carbapenems
          • Aminoglycosides
          • Sulfonamides
          • 7-ACA
          • Others
        • Spain Antibiotics Market, By Type
          • Branded Antibiotics
          • Generic Antibiotics
        • Spain Antibiotics Market, By Action Mechanism
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • Mycolic Acid Inhibitors
          • Others
      • Denmark
        • Denmark Antibiotics Market, By Drug Class
          • Cephalosporin
          • Penicillin
          • Fluoroquinolone
          • Macrolides
          • Carbapenems
          • Aminoglycosides
          • Sulfonamides
          • 7-ACA
          • Others
        • Denmark Antibiotics Market, By Type
          • Branded Antibiotics
          • Generic Antibiotics
        • Denmark Antibiotics Market, By Action Mechanism
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • Mycolic Acid Inhibitors
          • Others
      • Sweden
        • Sweden Antibiotics Market, By Drug Class
          • Cephalosporin
          • Penicillin
          • Fluoroquinolone
          • Macrolides
          • Carbapenems
          • Aminoglycosides
          • Sulfonamides
          • 7-ACA
          • Others
        • Sweden Antibiotics Market, By Type
          • Branded Antibiotics
          • Generic Antibiotics
        • Sweden Antibiotics Market, By Action Mechanism
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • Mycolic Acid Inhibitors
          • Others
      • Norway
        • Norway Antibiotics Market, By Drug Class
          • Cephalosporin
          • Penicillin
          • Fluoroquinolone
          • Macrolides
          • Carbapenems
          • Aminoglycosides
          • Sulfonamides
          • 7-ACA
          • Others
        • Norway Antibiotics Market, By Type
          • Branded Antibiotics
          • Generic Antibiotics
        • Norway Antibiotics Market, By Action Mechanism
          • Cell Wall Synthesis Inhibitors
          • Protein Synthesis Inhibitors
          • DNA Synthesis Inhibitors
          • RNA Synthesis Inhibitors
          • Mycolic Acid Inhibitors
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon